Applicant, as named in the Orange Book

Clivunel Inc

Next listed expiry: Scenesse on 20 Jan 2033. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Scenesse NDA 210797 afamelanotide	afamelanotide	20 Jan 2033 patent, carve-out possible	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.